Cleared Traditional

K813059 - LEECO TESTO-QUANT DIAG. KIT

K813059 is the FDA 510(k) clearance for LEECO TESTO-QUANT DIAG. KIT by Leeco Diagnostics, Inc.. It is a Class 1 Chemistry device (product code CDZ) cleared through the Traditional 510(k) pathway after a 17-day FDA review.

K813059 · Leeco Diagnostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1981
Decision
17d
Days
Class 1
Risk

K813059 is an FDA 510(k) clearance for the LEECO TESTO-QUANT DIAG. KIT. Classified as Radioimmunoassay, Testosterones And Dihydrotestosterone (product code CDZ), Class I - General Controls.

Submitted by Leeco Diagnostics, Inc. (Walker, US). The FDA issued a Cleared decision on November 16, 1981 after a review of 17 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1680 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Leeco Diagnostics, Inc. devices

Submission Details

510(k) Number K813059 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 30, 1981
Decision Date November 16, 1981
Days to Decision 17 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
71d faster than avg
Panel avg: 88d · This submission: 17d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1680
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone

All 53
Devices cleared under the same product code (CDZ) and FDA review panel - the closest regulatory comparables to K813059.
COAT-A-COUNT NO-EXTRACTION TESTOSTERONE
K831342 · Diagnostic Products Corp. · Jun 1983
LEECO TESTOSTERONE DIAGNOSTIC KIT
K830512 · Leeco Diagnostics, Inc. · Apr 1983
COAT-A-COUNT TESTOSTERONE RIA KIT
K813401 · Diagnostic Products Corp. · Dec 1981
LEECO TESTO-QUANT DIAGNOSTIC KIT
K803001 · Leeco Diagnostics, Inc. · Jan 1981
TESTOSTERONE RIA KIT (125I)
K772191 · Diagnostic Products Corp. · Jan 1978